Skip to main content
Top
Published in: BMC Neurology 1/2021

Open Access 01-12-2021 | Pituitary Adenoma | Research

Reversible splenial lesion syndrome with mental disorders as only manifestation

Authors: Ziyun Xu, Zhaoguang Zhou, Wentao Jang, Jianhong Tian, Gangqiang Hou

Published in: BMC Neurology | Issue 1/2021

Login to get access

Abstract

Background

Reversible splenial lesion syndrome (RESLES) was reported to be associated with variable entities. However, much less is known about the cases in which the mental disorders act as the only manifestation.

Method

Total ten patients of RESLES were obtained in this retrospective study from Shenzhen Kangning Hospital. T1-fluid attenuated inversion recovery (T1-FLAIR), T2-weighted images, T2-FLAIR, diffusion-weighted images and apparent diffusion coefficient map were performed on all the patients. Clinical manifestations, laboratory examination results, magnetic resonance imaging (MRI) findings, treatments and outcomes were analyzed.

Result

All patients showed different mental disorders as the only manifestation. There were two cases of alcohol abuse, one of Asperger’s syndrome with malnutrition, one of infection and one of invasive pituitary adenoma. The other cases were diagnosis as major depressive disorder, dissociative and conversion disorders, undifferentiated somatoform disorder, unspecified psychosis and bipolar disorder, respectively. Three patients were completely recovered while the clinical symptoms of rest seven patients partially recovered at the follow-up three months later. Oval-shaped lesion centered on the splenial of corpus callosum (SCC) was observed in all patients using MRI. The lesions of SCC of all patients were completely resolved within five weeks.

Conclusions

We found that RESLES might only showed mental symptoms. On the one hand, for the patients with acute mental disorders, clinicians should be alert to the possibility of RESLES caused by physical disease. On the other hand, we suggest that mental disorder might be a precipitating factor of RESLES.
Literature
1.
go back to reference Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia. 2005;46(10):1633–6.CrossRef Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia. 2005;46(10):1633–6.CrossRef
2.
go back to reference Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. Journal of neurology, neurosurgery, and psychiatry. 2001;70(4):459–63.CrossRef Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. Journal of neurology, neurosurgery, and psychiatry. 2001;70(4):459–63.CrossRef
3.
go back to reference Renard D, Bonafe A, Heroum C. Transient lesion in the splenium of the corpus callosum after oral corticoid therapy. European journal of neurology. 2007;14(8):e19-20.CrossRef Renard D, Bonafe A, Heroum C. Transient lesion in the splenium of the corpus callosum after oral corticoid therapy. European journal of neurology. 2007;14(8):e19-20.CrossRef
4.
go back to reference Gürtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005;65(7):1032–6.CrossRef Gürtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005;65(7):1032–6.CrossRef
5.
go back to reference Chen WX, Liu HS, Yang SD, et al. Reversible splenial lesion syndrome in children: Retrospective study and summary of case series. Brain & development. 2016;38(10):915–27.CrossRef Chen WX, Liu HS, Yang SD, et al. Reversible splenial lesion syndrome in children: Retrospective study and summary of case series. Brain & development. 2016;38(10):915–27.CrossRef
6.
go back to reference Malik AM. The reversible corpus callosum splenium lesion associated with hypoglycemic encephalopathy. The Neurohospitalist. 2013;3(3):169.CrossRef Malik AM. The reversible corpus callosum splenium lesion associated with hypoglycemic encephalopathy. The Neurohospitalist. 2013;3(3):169.CrossRef
7.
go back to reference Yang Q, Chang CC, Liu M, Yu YQ. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome. BMC medical imaging. 2019;19(1):35.CrossRef Yang Q, Chang CC, Liu M, Yu YQ. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome. BMC medical imaging. 2019;19(1):35.CrossRef
8.
go back to reference Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. Journal of neurology, neurosurgery, and psychiatry. 2014;85(2):168–73.CrossRef Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. Journal of neurology, neurosurgery, and psychiatry. 2014;85(2):168–73.CrossRef
9.
go back to reference Garcia-Monco JC, Martínez A, Brochado AP, Saralegui I, Cabrera A, Beldarrain MG. Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 2010;20(1):1–2.CrossRef Garcia-Monco JC, Martínez A, Brochado AP, Saralegui I, Cabrera A, Beldarrain MG. Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 2010;20(1):1–2.CrossRef
10.
go back to reference Oquist M, Farooq MU, Gorelick PB. Restricted diffusion of the splenium of the corpus callosum in viral meningitis. The Neurohospitalist. 2014;4(2):109–10.CrossRef Oquist M, Farooq MU, Gorelick PB. Restricted diffusion of the splenium of the corpus callosum in viral meningitis. The Neurohospitalist. 2014;4(2):109–10.CrossRef
11.
go back to reference Avcu G, Kilinc MA, Eraslan C, Karapinar B, Vardar F. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) associated with Streptococcus pneumoniae Bacteraemia. Journal of infection and public health. 2017;10(4):479–82.CrossRef Avcu G, Kilinc MA, Eraslan C, Karapinar B, Vardar F. Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) associated with Streptococcus pneumoniae Bacteraemia. Journal of infection and public health. 2017;10(4):479–82.CrossRef
12.
go back to reference Maeda M, Tsukahara H, Terada H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. Journal of neuroradiology = Journal de neuroradiologie. 2006;33(4):229–36.CrossRef Maeda M, Tsukahara H, Terada H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. Journal of neuroradiology = Journal de neuroradiologie. 2006;33(4):229–36.CrossRef
13.
go back to reference Devinsky O, Laff R. Callosal lesions and behavior: history and modern concepts. Epilepsy & behavior: E&B. 2003;4(6):607–17.CrossRef Devinsky O, Laff R. Callosal lesions and behavior: history and modern concepts. Epilepsy & behavior: E&B. 2003;4(6):607–17.CrossRef
14.
go back to reference Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. Radiographics: a review publication of the Radiological Society of North America, Inc. 2017;37(2):562–76.CrossRef Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. Radiographics: a review publication of the Radiological Society of North America, Inc. 2017;37(2):562–76.CrossRef
15.
go back to reference Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. Journal of the neurological sciences. 2020;415:116941.CrossRef Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. Journal of the neurological sciences. 2020;415:116941.CrossRef
16.
go back to reference Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging. 2011;21(2):e1-14.CrossRef Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging. 2011;21(2):e1-14.CrossRef
17.
go back to reference Hassel B, Boldingh KA, Narvesen C, Iversen EG, Skrede KK. Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. Journal of neurochemistry. 2003;87(1):230–7.CrossRef Hassel B, Boldingh KA, Narvesen C, Iversen EG, Skrede KK. Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. Journal of neurochemistry. 2003;87(1):230–7.CrossRef
18.
go back to reference Domercq M, Matute C. Expression of glutamate transporters in the adult bovine corpus callosum. Brain research Molecular brain research. 1999;67(2):296–302.CrossRef Domercq M, Matute C. Expression of glutamate transporters in the adult bovine corpus callosum. Brain research Molecular brain research. 1999;67(2):296–302.CrossRef
19.
go back to reference Goursaud S, Kozlova EN, Maloteaux JM, Hermans E. Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. Journal of neurochemistry. 2009;108(6):1442–52.CrossRef Goursaud S, Kozlova EN, Maloteaux JM, Hermans E. Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. Journal of neurochemistry. 2009;108(6):1442–52.CrossRef
20.
go back to reference Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR American journal of neuroradiology. 2005;26(2):216–28.PubMedPubMedCentral Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR American journal of neuroradiology. 2005;26(2):216–28.PubMedPubMedCentral
21.
go back to reference Takayama H, Kobayashi M, Sugishita M, Mihara B. Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clinical neurology and neurosurgery. 2000;102(3):135–9.CrossRef Takayama H, Kobayashi M, Sugishita M, Mihara B. Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clinical neurology and neurosurgery. 2000;102(3):135–9.CrossRef
22.
go back to reference Lee SH, Kim SS, Kim SH, Lee SY. Acute Marchiafava-Bignami disease with selective involvement of the precentral cortex and splenium: a serial magnetic resonance imaging study. The neurologist. 2011;17(4):213–7.CrossRef Lee SH, Kim SS, Kim SH, Lee SY. Acute Marchiafava-Bignami disease with selective involvement of the precentral cortex and splenium: a serial magnetic resonance imaging study. The neurologist. 2011;17(4):213–7.CrossRef
23.
go back to reference Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osmotic-induced demyelination. Experimental neurology. 2007;204(1):88–94.CrossRef Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osmotic-induced demyelination. Experimental neurology. 2007;204(1):88–94.CrossRef
24.
go back to reference Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta neurologica Scandinavica. 2002;106(6):379–86.CrossRef Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta neurologica Scandinavica. 2002;106(6):379–86.CrossRef
25.
go back to reference Yuan ZF, Shen J, Mao SS, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection. BMC infectious diseases. 2016;16:230.CrossRef Yuan ZF, Shen J, Mao SS, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection. BMC infectious diseases. 2016;16:230.CrossRef
26.
go back to reference Hantson P, Hernalsteen D, Cosnard G. Reversible splenial lesion syndrome in cerebral malaria. Journal of neuroradiology = Journal de neuroradiologie. 2010;37(4):243–6.CrossRef Hantson P, Hernalsteen D, Cosnard G. Reversible splenial lesion syndrome in cerebral malaria. Journal of neuroradiology = Journal de neuroradiologie. 2010;37(4):243–6.CrossRef
27.
go back to reference Kaino K, Kumagai R, Furukawa S, et al. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. Journal of diabetes investigation. 2017;8(3):392–4.CrossRef Kaino K, Kumagai R, Furukawa S, et al. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. Journal of diabetes investigation. 2017;8(3):392–4.CrossRef
28.
go back to reference Udaya SC, Chauhan BN, Philip VJ. Bright splenium of a psychotic mind. Annals of Indian Academy of Neurology. 2015;18(1):80–3.PubMedPubMedCentral Udaya SC, Chauhan BN, Philip VJ. Bright splenium of a psychotic mind. Annals of Indian Academy of Neurology. 2015;18(1):80–3.PubMedPubMedCentral
Metadata
Title
Reversible splenial lesion syndrome with mental disorders as only manifestation
Authors
Ziyun Xu
Zhaoguang Zhou
Wentao Jang
Jianhong Tian
Gangqiang Hou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-021-02391-6

Other articles of this Issue 1/2021

BMC Neurology 1/2021 Go to the issue